Russia ( Europe Brief News): Analysts report Russia’s ED drug sales hit 3.9B rubles in early 2025, revealing a 12.3% rise and ranking the top 10 erectile dysfunction medications.
More than 6 million packages of natural units were sold, representing an 8.7% increase from January to May 2024. Almost all of these top ten medications are generics, according to data from RNC Pharma.
Experts say that significant fundamental shifts are causing the existing market dynamics to change. The volume of ruble sales in this category fell by 12.8% in 2023 after a number of original medications were removed from the Russian market.
Generic medications were able to counteract this decrease, though. Physical sales increased despite a decline in revenue.
The decline in the average cost of therapy is another noteworthy development. The average cost of a single packet of the medication was 643 rubles between January and May of 2025, an 18% drop from the three years before.
This decline is the result of normal pricing dynamics in the pharmaceutical industry as well as a shift in market structure that favors less expensive generics.
38 brands of erectile dysfunction medications, the most of which are made domestically, are available on the Russian market, according to data from the first five months of this year. With 46% of physical sales and more than 36% of the market in rubles, Severnaya Zvezda was in the lead.
Four products based on sildenafil, tadalafil, and dapoxetine are available from the manufacturer.
Meanwhile, there is still a strong demand for unbranded sildenafil medications. Eleven firms produce these medications, with Severnaya Zvezda being the most well-known. Together, the different versions of tadalafil hold a 23.6% market share, placing them in second place.
Teva Pharmaceutical’s medication Dynamico (sildenafil), which earned 14% in cash, comes in third.
One of the new products that has seen a notable increase in sales is the Tadanord, which is manufactured by Severnaya Zvezda. Nearly all medications on the market are made in Russia, according to analysts, suggesting complete import replacement in this pharmaceutical market category.
What are the key drugs in the Russian ED market?
The most widely used active component, present in both generic and name-brand medications, including Viagra. Because of its well-established effectiveness and broad recognition, sildenafil continues to be a popular option.
Tadalafil, commonly known as Cialis, is popular in Russia and is known for its prolonged duration of action, which gives patients a more flexible window for when to take it.
Products from certain manufacturers combine dapoxetine, which treats premature ejaculation, with ED medication to provide a twofold benefit.
In contrast to sildenafil and tadalafil, medications such as vardenafil (Levitra) and avanafil (Stendra) are available but less common in the Russian market.
After being approved and introduced in Russia, Zydena (udenafil), a long-acting ED medication with fewer side effects, is anticipated to take a sizable portion of the market alongside well-known medications.
